678 related articles for article (PubMed ID: 34674600)
1. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the interplay between m
Yi YC; Chen XY; Zhang J; Zhu JS
Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
Han J; Kong H; Wang X; Zhang XA
Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
6. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
7. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
9. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
10. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
[TBL] [Abstract][Full Text] [Related]
12. N
Li J; Liang L; Yang Y; Li X; Ma Y
Theranostics; 2021; 11(6):2581-2593. PubMed ID: 33456561
[TBL] [Abstract][Full Text] [Related]
13. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
[TBL] [Abstract][Full Text] [Related]
15. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
[TBL] [Abstract][Full Text] [Related]
17. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAS and colorectal cancer liver metastasis.
Zhou XY; Luo B; Jiang ZK; Xie YK; Wu FC; Huang JQ; Chen JS
Mol Cell Biochem; 2020 Dec; 475(1-2):151-159. PubMed ID: 32767228
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
Front Immunol; 2021; 12():769204. PubMed ID: 34880865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]